DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. The Animal Nutrition & Health segment offers animal proteins, vitamins, performance solutions, and data-driven precision services. The company was founded in 1902 and is based in Kaiseraugst, Switzerland.
The current price of DSMFF is $70.78 USD — it has increased by +5.63% in the past 24 hours. Watch DSM-Firmenich stock price performance more closely on the chart.
What is DSM-Firmenich stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange DSM-Firmenich stocks are traded under the ticker DSMFF.
When is the next DSM-Firmenich earnings date?▼
DSM-Firmenich is going to release the next earnings report on July 30, 2026.
What were DSM-Firmenich earnings last quarter?▼
DSMFF earnings for the last quarter are 0.99 USD per share, whereas the estimation was 1.96 USD resulting in a -49.7% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is DSM-Firmenich revenue for the last year?▼
DSM-Firmenich revenue for the last year amounts to 29.42B USD.
What is DSM-Firmenich net income for the last year?▼
DSMFF net income for the last year is -2.53B USD.
Does DSM-Firmenich pay dividends?▼
Yes, DSMFF dividends are paid annual. The last dividend per share was 1.19 USD. As of today, Dividend Yield (FWD)% is 1.41%.
When did DSM-Firmenich complete a stock split?▼
DSM-Firmenich has not had any recent stock splits.
Where is DSM-Firmenich headquartered?▼
DSM-Firmenich is headquartered in Kaiseraugst, CH.